238 related articles for article (PubMed ID: 33640432)
1. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.
Lymperopoulos A; Borges JI; Carbone AM; Cora N; Sizova A
Pharmacol Res; 2021 Dec; 174():105943. PubMed ID: 34662735
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy.
Lymperopoulos A; Aukszi B
World J Cardiol; 2017 Mar; 9(3):200-206. PubMed ID: 28400916
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-dependent aldosterone production in the adrenal cortex.
Lymperopoulos A; Borges JI; Suster MS
Vitam Horm; 2024; 124():393-404. PubMed ID: 38408805
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
6. Biased agonism/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy.
Maning J; Negussie S; Clark MA; Lymperopoulos A
Pharmacol Res; 2017 Nov; 125(Pt A):14-20. PubMed ID: 28511989
[TBL] [Abstract][Full Text] [Related]
7. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.
Li A; Liu S; Huang R; Ahn S; Lefkowitz RJ
PLoS One; 2023; 18(3):e0283477. PubMed ID: 36961836
[TBL] [Abstract][Full Text] [Related]
8. Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
Takezako T; Unal H; Karnik SS; Node K
Pharmacol Res; 2017 Sep; 123():40-50. PubMed ID: 28648738
[TBL] [Abstract][Full Text] [Related]
9. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II cyclic analogs as tools to investigate AT
St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
[TBL] [Abstract][Full Text] [Related]
11. RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting.
Lymperopoulos A; Borges JI; Stoicovy RA
Biochem Pharmacol; 2023 Dec; 218():115904. PubMed ID: 37922976
[TBL] [Abstract][Full Text] [Related]
12. Biased Agonism of the Angiotensin II Type I Receptor.
Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
[TBL] [Abstract][Full Text] [Related]
13. Biased agonism of the angiotensin II type 1 receptor.
Godin CM; Ferguson SS
Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
[TBL] [Abstract][Full Text] [Related]
14. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.
Gagnon L; Cao Y; Cho A; Sedki D; Huber T; Sakmar TP; Laporte SA
J Biol Chem; 2019 Nov; 294(46):17409-17420. PubMed ID: 31530642
[TBL] [Abstract][Full Text] [Related]
15. Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison.
Dabul S; Bathgate-Siryk A; Valero TR; Jafferjee M; Sturchler E; McDonald P; Koch WJ; Lymperopoulos A
Sci Rep; 2015 Jan; 5():8116. PubMed ID: 25631300
[TBL] [Abstract][Full Text] [Related]
16. Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR).
Strachan RT; Sun JP; Rominger DH; Violin JD; Ahn S; Rojas Bie Thomsen A; Zhu X; Kleist A; Costa T; Lefkowitz RJ
J Biol Chem; 2014 May; 289(20):14211-24. PubMed ID: 24668815
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Galandrin S; Denis C; Boularan C; Marie J; M'Kadmi C; Pilette C; Dubroca C; Nicaise Y; Seguelas MH; N'Guyen D; Banères JL; Pathak A; Sénard JM; Galés C
Hypertension; 2016 Dec; 68(6):1365-1374. PubMed ID: 27698068
[TBL] [Abstract][Full Text] [Related]
18. Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gα
Wang J; Hanada K; Gareri C; Rockman HA
J Cell Biochem; 2018 Apr; 119(4):3586-3597. PubMed ID: 29231251
[TBL] [Abstract][Full Text] [Related]
19. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
[TBL] [Abstract][Full Text] [Related]
20. GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo.
Pollard CM; Ghandour J; Cora N; Perez A; Parker BM; Desimine VL; Wertz SL; Pereyra JM; Ferraino KE; Patel JJ; Lymperopoulos A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
